Clinical Trial

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 19, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to evaluate temporal delay (days) between biliary drainage (EUS-CDS vs ERCP as first line therapy) and chemotherapy start in patients with borderline distal malignant biliary obstruction.
Trial Details
NCT Number NCT06375954
Lead Sponsor Hospital Universitari de Bellvitge
Collaborators: Hospital Mutua de Terrassa, Hospital Clínico Universitario de Valencia, Hospital General Universitario de Alicante, Hospital Universitario Ramon y Cajal, Hospital General Universitario de Castellón, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Santiago, University Hospital Virgen de las Nieves, Complejo Hospitalario de Navarra, Hospital de Sant Pau, University of Salamanca
Conditions Malignant Biliary Obstruction, Pancreatic Cancer, Biliary Tract Neoplasms
Enrollment 96 participants
Start Date 2024-05-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-19